Neurofunction > Volume 22(2); 2026 > Article
Park, Park, and Kim: Utility of preoperative magnetic resonance imaging features for predicting postoperative outcomes in patients with idiopathic normal pressure hydrocephalus

Abstract

Objective

We investigated associations between postoperative outcomes and clinical characteristics and magnetic resonance imaging (MRI) findings, including disproportionately enlarged subarachnoid space hydrocephalus (DESH) features, in patients with idiopathic normal pressure hydrocephalus (iNPH). We also evaluated the usefulness of these features for predicting outcomes compared with the cerebrospinal fluid (CSF) tap test.

Methods

This retrospective cohort study included 36 patients with iNPH who underwent ventriculoperitoneal shunt surgery. Clinical outcomes were assessed from changes in modified Rankin Scale scores at least 1 year after surgery. Cognitive function was evaluated using the Mini-Mental State Examination, and gait function was assessed using the 8-m walk test. Preoperative MRI findings were quantified using the DESH score.

Results

Overall, 28 patients (77.8%) were classified as responders and 8 (22.2%) as nonresponders. Baseline clinical characteristics, the Evans index, and mean DESH scores did not differ significantly between the groups. A positive CSF tap test response (≥10% gait improvement) was significantly more frequent among responders than among nonresponders (57.1% vs. 12.5%; p=0.044). In multivariable regression, the DESH score was not independently associated with outcomes (p=0.885), whereas a positive tap test response showed a strong trend toward an association (p=0.078).

Conclusion

This study demonstrated the role of the DESH features as noninvasive diagnostic factors for iNPH. However, their value in predicting treatment response could not be established in comparison with the CSF tap test. Further studies are needed to develop noninvasive predictors of treatment efficacy in iNPH.

INTRODUCTION

Idiopathic normal pressure hydrocephalus (iNPH) is a disease characterized by a triad of three typical symptoms: gait disturbance, dementia, and urinary disturbance [1]. It can be treated with cerebrospinal fluid (CSF) diversion surgery such as ventriculo-peritoneal (VP) or lumbo-peritoneal shunt. However, symptom improvement after treatment is very variable across reports, with 41-95% within 1 year postoperatively and 28-91% for long-term outcome up to 3-5 years [2]. Over time, the shunt response rate has shown a gradual improvement trend, but some reports have focused on and highlighted low shunt response rates [3-6].
Therefore, precise patient selection prior to shunt surgery is essential for favorable treatment outcomes. For accurate patient selection, it is necessary to identify factors that act as an outcome predictor during various diagnostic test processes, patient characteristics, and symptom presentations.
While the CSF tap test has been recognized as one of the representative outcome predictors, reports are emerging that various features of magnetic resonance imaging (MRI) can serve as an outcome predictor due to technological advancements in diagnostic imaging study such as MRI [7].
Among the MRI findings of iNPH patients, disproportionately enlarged subarachnoid space hydrocephalus (DESH)—a finding consisting of ventriculomegaly, dilated Sylvian fissures, tight high convexity, acute callosal angle, and focal sulcal dilation—is emerging as a biomarker for diagnosis and treatment efficacy. Since Kitagaki et al. [8] first reported the appearance of DESH in brain imaging in 1998, DESH has now become a prominent characteristic finding of iNPH and is one of the diagnostic criterion for iNPH in the updated Japanese iNPH guidelines [9]. There are several reports stating that this DESH finding is valuable as an outcome predictor for the response to shunt [10-14].
In this study, we aim to investigate the association between postoperative outcome and various features, including clinical characteristics and various MRI findings, encompassing DESH features of iNPH patients, and to evaluate its usefulness in predicting postoperative symptom improvement compared to the CSF tap test.

MATERIALS AND METHODS

Study design and patient population

The study was approved by the institutional review board (IRB) of Gachon University Gil Medical Center (IRB approval number: GAIRB2026-367) and adhered to the principles set forth in the Declaration of Helsinki. This retrospective, single-center observational cohort study included patients with iNPH who underwent CSF diversion surgery at our institution between March 2011 and November 2022. Clinical records and preoperative neuroimaging data were reviewed retrospectively.
Patients were eligible for inclusion if they had clinical features suggestive of iNPH, including gait disturbance, cognitive impairment, and/or urinary disturbance, and if both preoperative and postoperative modified Rankin Scale (mRS) scores were available. Patients were excluded if clinical records were insufficient, postoperative functional outcome data were unavailable, or ventriculomegaly was attributable to secondary causes such as hemorrhage, infection, trauma, or tumor.
The shunt surgery criteria at our institution were as follows: 1) ventriculomegaly with an Evans index >0.3, 2) classic symptom triad of iNPH (cognitive decline, urinary disturbance, and gait disturbance), and 3) gait improvement following the CSF tap test. Shunt surgery was recommended if two or more of these criteria were met.
A total of 36 patients who underwent VP shunt surgery were included in the final analysis. Because all included patients received the same type of CSF diversion procedure (VP shunt using Codman Hakim® programmable valve), heterogeneity related to shunt type was minimized. Demographic variables, clinical symptoms, CSF tap test response, preoperative and postoperative functional status, and radiological parameters were collected.

Clinical variable

The clinical variables reviewed were age at surgery, sex, symptom duration, preoperative cognitive function, gait disturbance, urinary disturbance, preoperative mRS score, CSF tap test response, postoperative mRS score, and clinical outcome. Preoperative cognitive function was assessed using the Mini-Mental State Examination. Symptom duration was defined as the interval between the onset of symptoms attributable to iNPH and the date of surgery. When symptom duration was recorded in years, it was converted into months for statistical analysis. Gait disturbance was assessed from documented clinical descriptions, including short-stepped gait, wide-based gait, dragging gait, ataxia, frequent falls, or inability to walk. Urinary disturbance was assessed from documented clinical descriptions, including frequency, incontinence, urgency, or nocturia and scored as 0 when absent and 1 when present.
The CSF tap test response was assessed using the 8-m walk test before and 2 hour after 30 to 50 mL lumbar CSF drainage. If the patients complained of dizziness or back pain and were unable to walk, their ability to walk was assessed 6 hours after lumbar CSF drainage. Improvement was defined as the reduction in walking time after CSF drainage compared with the baseline 8-m walk time before drainage. The percentage improvement was calculated as follows: [(pre-drainage 8-m walk time-post-drainage 8-m walk time)/pre-drainage 8-m walk time]×100. The response was scored as 0 for no improvement, 1 for improvement of less than 10%, and 2 for improvement of 10% or greater. A score of 2 was regarded as a positive tap test response.

Radiological assessment

Preoperative brain MRI studies were reviewed to evaluate radiological features associated with iNPH. MRI included axial T2-weighted images, axial FLAIR images, and coronal T2-weighted or FLAIR images. The evaluated radiological parameters included Evans index, high-convexity sulcal narrowing, Sylvian fissure widening, focally enlarged sulci, temporal horn widening, callosal angle, narrow callosal angle, DESH score, and periventricular hyperintensity. These imaging features were visually assessed by one clinician, E.Y. Kim.
The definition and measurement method of each parameter were as follows. The Evans index was measured on transverse images as the ratio between the maximum diameter of the frontal horns of the lateral ventricles and the maximum inner diameter of the skull in the same section [7]. Dilated Sylvian fissures were determined by observing the width of bilateral Sylvian fissures on coronal images at the level of the central part of the brainstem [7]. Tight high convexity sulci were determined by observing whether there was compression of the medial and/or high convexity cortical sulci (narrow sulci) on coronal images [7]. The callosal angle was the angle between the lateral ventricles through the posterior commissure and perpendicular to the anteriorposterior commissure plane measured on a coronal image [7]. Focal sulcal dilation is the accumulation of CSF in focally enlarged sulci [7].

Disproportionately enlarged subarachnoid space hydrocephalus score

The DESH score was calculated by summing five radiological components: ventriculomegaly based on the Evans index, Sylvian fissure widening, tight high-convexity sulci, narrow callosal angle, and focally enlarged sulci. Each component was scored from 0 to 2, yielding a total score ranging from 0 to 10 points. Higher scores represented a higher degree of DESH features (Table 1) [7].

Additional imaging variables

Temporal horn width was measured at the widest portion of each temporal horn of the lateral ventricles. Periventricular hyperintensity was evaluated on T2 FLAIR images [7]. It was graded as 0 for normal findings, including a “pencil-thin lining” along the ventricular wall and small caps around the frontal horns; 1 for increased periventricular hyperintensity; and 2 for irregular large symmetric hyperintensities extending into the deep white matter and, in at least two locations, all the way from the ventricles to the cortex [7]. For group comparisons of categorical imaging findings, scores of 1 or 2 were considered present [15].

Outcome assessment

Postoperative functional improvement was assessed by comparing preoperative and postoperative mRS scores. The mRS was used to assess global functional disability. The mRS ranges from 0 to 6, with higher scores indicating greater disability; a score of 0 indicates no symptoms, whereas a score of 6 indicates death [16]. Clinical outcome was assessed at least 1 year after surgery and classified into three categories according to the magnitude of improvement in the mRS score: minimal response was defined as no or minimal change between the preoperative and postoperative mRS scores, moderate response as a 1-point improvement, and good response as an improvement of 2 or more points. For the main comparative analysis, patients with good or moderate response were classified as responder, whereas those with minimal response were classified as nonresponder.

Statistical analysis

Continuous variables were expressed as mean±standard deviation with range for overall baseline characteristics and as mean±standard error for between-group comparisons, unless otherwise specified. Categorical variables were expressed as frequencies and percentages.
Comparisons between nonresponder and responder were performed using the Mann-Whitney U-test for continuous or ordinal variables and Fisher’s exact test for categorical variables, as appropriate. Univariable logistic regression analysis was performed to identify factors associated with postoperative responder status. Variables with clinical relevance or a p-value less than 0.20 in univariable analysis were considered for multivariable logistic regression. Because of the relatively small sample size, the number of variables included in the multivariable model was limited to reduce overfitting, and multivariable results were interpreted as exploratory.
Statistical significance was defined as a two-sided p-value <0.05. All statistical analyses were performed using SPSS software (IBM Corp.). Because all patients underwent VP shunt surgery, shunt type was not included as a comparative variable in the statistical analysis.

RESULTS

Baseline characteristics

The baseline characteristics of the 36 patients are summarized in Table 2. The mean age at operation was 72.0±7.8 years, and 24 patients (66.7%) were male. The mean symptom duration was 25.2±25.2 months, and urinary disturbance was observed in 29 patients (80.6%). On preoperative imaging, the mean Evans index was 0.371±0.039, the mean callosal angle was 98.8±23.2°, and the mean DESH score was 5.1±2.3. An Evans index score of 2 was observed in 27 patients (75.0%), indicating that most patients showed definite ventriculomegaly.

Distribution of disproportionately enlarged subarachnoid space hydrocephalus and tap test scores

The distributions of DESH scores and tap test response scores according to shunt response are shown in Fig. 1 and 2. DESH scores were widely distributed and largely overlapped between the nonresponder group and responder group. The mean DESH score did not differ significantly between the two groups (5.38±1.03 vs. 5.00±0.41, p=0.695). In contrast, tap test response scores tended to be higher in the responder. A positive tap test response score of 2 was observed in 16 of 28 responder (57.1%), compared with 1 of 8 nonresponder (12.5%).

Comparison according to shunt response

Baseline clinical and radiological characteristics according to shunt response are presented in Table 3. Of the 36 patients included in the analysis, 8 (22.2%) were classified as nonresponder and 28 (77.8%) as responder. There were no significant differences between the two groups in age, symptom duration, Evans index, temporal horn width, callosal angle, or DESH score. Among categorical variables, urinary disturbance, high-convexity sulcal narrowing, focally enlarged sulci, and periventricular hyperintensity did not differ significantly between groups.
A favorable tap test response was more frequently observed in responder group than in nonresponder group. Among nonresponder group, tap test response scores of 0, 1, and 2 were observed in 3 of 8 (37.5%), 4 of 8 (50.0%), and 1 of 8 (12.5%) patients, respectively; among responders, the corresponding values were 4 of 28 (14.3%), 8 of 28 (28.6%), and 16 of 28 (57.1%). When analyzed according to tap test response score, the observed probability of postoperative responder status increased numerically from 57.1% (4/7) for score 0 to 66.7% (8/12) for score 1 and 94.1% (16/17) for score 2. A positive tap test response (score 2) was significantly more frequent among responder group than nonresponder group (57.1% vs. 12.5%, p=0.044). 12 of 19 patients (63.2%) with a negative tap test (scores 0 or 1) nevertheless responded to shunt surgery.

Multivariable logistic regression analysis

The results of the revised multivariable logistic regression analysis are summarized in Table 4 and Fig. 3. DESH score was not independently associated with responder status (adjusted odds ratio [OR], 0.955; 95% confidence interval [CI], 0.508-1.795; p=0.885). Other radiological variables, including periventricular hyperintensity, bilateral temporal horn width, and high-convexity sulcal narrowing, were also not significantly associated with postoperative responder status. Positive tap test response showed a trend toward association with responder status, although it did not reach statistical significance after adjustment (adjusted OR, 3.725; 95% CI, 0.863-16.083; p=0.078).

DISCUSSION

We defined our iNPH cohort as patients exhibiting the classical symptom triad (gait disturbance, dementia, and urinary disturbance) accompanied by ventriculomegaly (Evans index≥0.3), after thoroughly excluding other potential etiologies. These patients underwent baseline brain MRIs and CSF tap tests, followed by a VP shunt operation. When evaluating the surgical efficacy over a follow-up period of more than one year, we observed a clinically meaningful improvement—defined as a decrease of 1 or more points on the mRS—in approximately 78% of the cases. These favorable outcomes are highly consistent with findings from other studies [2,17].
In the present study, we investigated the association between surgical outcomes and widely recognized predictors of postoperative success, namely the CSF tap test and specific preoperative MRI features. These MRI parameters included temporal horn width, periventricular hyperintensities, and the radiological findings of DESH, which consist of ventriculomegaly, dilated Sylvian fissures, tight high convexity, an acute callosal angle, and focal sulcal dilation.
Primarily, the CSF tap test has been performed as a standard preoperative assessment for iNPH. The underlying theory is that shunt placement drains CSF, which subsequently decreases resistance to CSF outflow, enhances regional cerebral blood flow, and ultimately leads to symptom improvement [17]. With a reported sensitivity of 28-62% and a specificity of 33-100%, the CSF tap test is not only highly valuable in diagnosing iNPH, but has also been regarded as a reliable outcome predictor, as it allows clinicians to directly estimate the potential clinical benefits of CSF withdrawal [2].
Consistent with previous findings, our study demonstrated a graded association between the magnitude of gait improvement after the CSF tap test and postoperative shunt response. The observed proportion of responder increased numerically across tap test response scores, from 57.1% in patients with score 0 to 66.7% in those with score 1 and 94.1% in those with score 2. In multivariable analysis, a positive tap test response (score 2) was associated with 3.725-fold higher odds of responder status. Importantly, 63.2% with a negative tap test (scores 0 or 1) nevertheless responded to shunt surgery, highlighting the possibility of false-negative results and suggesting that a negative tap test should be interpreted cautiously when selecting surgical candidates. Consequently, ongoing efforts are dedicated to identifying more sensitive and specific diagnostic modalities to accurately diagnose iNPH and optimize patient selection for favorable surgical outcomes.
One such method is continuous CSF drainage. Also referred to as the external lumbar drainage (ELD) test, this procedure involves the removal of a large volume of CSF (300-500 mL) over several days via an ELD [2,18-23]. Despite demonstrating a higher sensitivity (60-100%) and specificity (80-100%) than the standard tap test, continuous drainage is not widely utilized due to significant practical limitations, namely the difficulty of prolonged catheter maintenance and the challenges of administering the test to patients with dementia [3,19-23]. Intrathecal infusion tests, which measure resistance to CSF outflow and intracranial compliance, directly assess CSF dynamics—the most critical factor in iNPH. Although these tests are known to yield the highest predictive value, their clinical application is hindered by several drawbacks, including the need for specialized equipment, greater invasiveness, and the time-consuming nature of the procedure [17].
Recently, technological advancements in diagnostic imaging, particularly MRI, have prompted numerous studies based on the hypothesis that certain characteristic MRI features of iNPH may correlate with surgical outcomes or treatment efficacy. If such predictive preoperative findings are identified, clinicians could easily and safely recommend surgical intervention, accurately prognosticate outcomes, and ultimately determine the most effective strategy between surgical and medical treatments.
Previously, a multicenter, prospective cohort study demonstrated the high utility of an MRI-based diagnostic scheme, proving that the DESH sign holds significant diagnostic value for iNPH [11]. The clinical significance of DESH in communicating hydrocephalus lies in its distinct distribution of CSF. The coexistence of tight high convexity subarachnoid spaces with enlarged ventricles and dilated Sylvian fissures indicates that the enlargement of the subarachnoid space is predominantly confined to the inferior compartments. This focal enlargement serves as a critical differentiating factor from general cerebral atrophy [11]. Multiple cerebral blood flow studies have revealed that in patients with iNPH, perfusion is more severely reduced in the white matter surrounding the ventricles compared to the subcortical white matter [24]. Furthermore, other studies have reported neuronal degeneration and gliosis within the periventricular brain tissue, presumably driven by altered extracellular fluid dynamics [25,26]. Drawing upon these findings, it can be postulated that DESH is a radiographic manifestation resulting from the compression of paraventricular white matter and the subsequent blockage of physiologic CSF circulation [27]. Recognizing the DESH finding as a crucial diagnostic hallmark that elucidates the pathophysiology of iNPH, Shinoda et al. [7] introduced a DESH scale to quantitatively evaluate its radiological appearance and investigated its utility as a predictor of treatment efficacy. In line with their pioneering work, the present study also employed this DESH scale.
While the diagnostic utility of the DESH sign and its individual components for iNPH is well established, we conducted this study hypothesizing that their validation as predictors of treatment efficacy would greatly benefit patients by enabling the precise selection of surgical candidates without the need for invasive testing. Contrary to our expectations, however, neither the total DESH scale nor its individual parameters, nor other MRI features such as temporal horn width and periventricular hyperintensities, demonstrated a statistically significant association with shunt response.
The finding that DESH and other MRI features hold a low predictive value for treatment efficacy is consistent with the results reported in previous meta-analyses [28,29]. Specifically, Park et al. [28] reported the poor diagnostic performance of DESH with regard to the prediction of treatment response, noting a pooled sensitivity of 59% and a specificity of 66%, and described a relatively low prevalence of DESH (44%) in patients with iNPH.
The difficulty in establishing the value of MRI features, particularly DESH, as outcome predictors for iNPH can be attributed to the underlying pathophysiology of the disease. Previous studies have demonstrated that shunt responders exhibit significantly elevated dynamic (pulsatile) intracranial pressure (ICP), typically expressed as the mean ICP wave amplitude. This suggests that decreased intracranial compliance plays a crucial role in the pathogenesis of iNPH. CSF diversion via shunt surgery restores this impaired compliance, thereby leading to symptom improvement.
Consequently, static anatomical markers on MRI are inherently limited in their ability to fully capture the dynamic biomechanical alterations of the brain and accurately predict surgical outcomes [18,30-32]. Furthermore, as previously reported, the most accurate predictor of shunt response is ICP monitoring of pulse pressure (mean ICP wave amplitude), followed by ELD and infusion testing. Therefore, at present, it must be acknowledged that these invasive tests hold the greatest value as outcome predictors [18,30,33].
Secondly, the limited predictive value of MRI features can be attributed to the presence of comorbidities. One study found a high prevalence of vascular comorbidities among iNPH patients, reporting that their frequency was more than 4 to 5 folds higher specifically in shunt nonresponders [21]. Other studies have also indicated that the development of iNPH is associated with vascular diseases, such as hypertension, ischemic heart disease, and diabetes [34-39]. Moreover, iNPH often coexists with other neurodegenerative disorders, notably Alzheimer’s disease and Parkinson’s disease. This presents a significant diagnostic challenge, as both the clinical presentation and structural MRI features of iNPH frequently mimic those of these concurrent neurodegenerative conditions [35,40]. In one study, brain biopsies performed during shunt surgery revealed one or several concurrent disorders were present in 89% of the patients, most often cerebrovascular disease and possible Alzheimer’s disease, or both [41]. Thus, in elderly patients, the presence of such comorbidities acts as a crucial confounding factor that complicates accurate diagnosis and the prediction of treatment outcomes [2].
Given the clear benefits to both patients and clinicians, the search for noninvasive or less invasive modalities capable of predicting surgical outcomes remains a highly worthwhile pursuit. Accordingly, continuous research efforts in this direction are strongly warranted.
Prompted by the limited predictive value of conventional MRI features like the DESH sign, recent studies have increasingly focused on advanced imaging techniques such as Diffusion Tensor Imaging to evaluate microstructural white matter alterations in iNPH or MRI techniques designed to visualize CSF flow [40,42-44]. Thus, it could be useful to include these techniques in the routine magnetic resonance protocol for patients with iNPH, as they are emerging as promising noninvasive biomarkers for predicting surgical outcomes.
Recently, a growing body of literature has leveraged deep learning frameworks to analyze diagnostic tests and assessments for iNPH, thereby facilitating more precise clinical evaluation and treatment outcome prediction [29,45]. As multifaceted research integrating machine learning and artificial intelligence continues to evolve—allowing for granular data analysis and the identification of complex clinical correlations—these advanced technologies are poised to play a transformative role in the diagnosis and therapeutic management of iNPH.
The limitations of this study should be acknowledged. First, the small number of cases limited our ability to statistically prove the correlation between each variable and treatment response. Second, given the retrospective study design, the scoring of MRI imaging parameters relied on the unblinded judgment of a single clinician. The DESH scoring system involves the evaluator’s subjective judgment to assess the extent of dilation, narrowness, or hyperintensity of each imaging parameter. Consequently, this study inherently has limitations compared to scores evaluated by multiple independent raters, such as radiologists, who are uninvolved in patient care. Lastly, the outcome was measured using the mRS. Because this scale reflects the subjective evaluations of patients and caregivers, it has the limitation of being less objective in assessing symptom severity compared to quantifiable assessments such as activities of daily living or walking speed.

CONCLUSION

This study demonstrated that the DESH score and its components—ventriculomegaly, dilated Sylvian fissures, tight high convexity, acute callosal angle, and focal sulcal dilation—act as noninvasive diagnostic factors for iNPH. However, their role as a predictor of treatment-response could not be established. Conversely, a positive CSF tap test showed a significant unadjusted association with treatment response and a trend toward association after multivariable adjustment.
Consequently, invasive procedures evaluating CSF flow and ICP dynamics remain necessary for precise prediction. To develop noninvasive predictors of iNPH treatment efficacy, further studies are required to analyze MRI features as biomarkers through functional imaging studies showing CSF flow dynamics or by integrating machine learning.

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

ACKNOWLEDGEMENTS

This work was supported by the Gachon University research funds for 2023 (GCU-202310160001) and 2024 (GCU-202409460001).

Fig. 1.
Distribution of disproportionately enlarged subarachnoid space hydrocephalus (DESH) scores by shunt response. DESH scores spanned a wide range, with overlapping distributions in responders and nonresponders.
nf-2026-00241f1.jpg
Fig. 2.
Distribution of tap test response scores by shunt response. A score of 2, indicating a positive tap test response, was more common among responders.
nf-2026-00241f2.jpg
Fig. 3.
Forest plot of adjusted odds ratios for shunt responder status. CI: confidence interval, DESH: disproportionately enlarged subarachnoid space hydrocephalus.
nf-2026-00241f3.jpg
Table 1.
DESH scoring system [7]
Radiological parameter 0 points 1 point 2 points
Ventriculomegaly Evans index<0.30 Evans index 0.30-0.35 Evans index>0.35
Sylvian fissure widening Normal or narrow Mild or unilateral widening Bilateral widening
High-convexity sulcal narrowing Normal or wider than normal Mild compression Definite compression
Callosal angle >100° 90-100° <90°
Focally enlarged sulci Absent Some present Many present
Total DESH score 0-10 points

Scores for the Evans index, high-convexity sulcal narrowing, Sylvian fissure widening, focally enlarged sulci, and a narrow callosal angle were assigned using this magnetic resonance imaging-based DESH scoring system. DESH: disproportionately enlarged subarachnoid space hydrocephalus.

Table 2.
Baseline clinical and radiological characteristics
Characteristic Value
No. of patients 36 (100)
Clinical characteristics
 Age at surgery (yr) 72.0±7.8 (56-88)
 Male sex 24 (66.7)
 Female sex 12 (33.3)
 Symptom duration (mo) 25.2±25.2 (1-108)
 MMSE 21.2±5.2 (7-28)
 Urinary disturbance 29 (80.6)
 No urinary disturbance 7 (19.4)
Tap test response score*
 0 7 (19.4)
 1 12 (33.3)
 2 17 (47.2)
Radiological characteristics
 Evans index 0.371±0.039 (0.29-0.44)
 Right temporal horn width (mm) 8.8±3.3 (3.0-17.4)
 Left temporal horn width (mm) 8.7±2.8 (3.0-13.8)
 Callosal angle (°) 98.8±23.2 (58.7-135.0)
 DESH score 5.1±2.3 (1-9)
Evans index score†
 0 1 (2.8)
 1 8 (22.2)
 2 27 (75.0)
High-convexity sulcal narrowing score†
 0 20 (55.6)
 1 11 (30.6)
 2 5 (13.9)
Sylvian fissure widening score†
 0 7 (19.4)
 1 14 (38.9)
 2 15 (41.7)
Focally enlarged sulci score†
 0 17 (47.2)
 1 15 (41.7)
 2 4 (11.1)
Narrow callosal angle score†
 0 19 (52.8)
 1 1 (2.8)
 2 16 (44.4)
Periventricular hyperintensity score‡
 0 18 (50.0)
 1 15 (41.7)
 2 3 (8.3)

Values are presented as number (%) or mean±standard deviation (range). Symptom duration is expressed in months. MMSE: Mini-Mental State Examination, DESH: disproportionately enlarged subarachnoid space hydrocephalus.

*A score of 0 indicated no improvement; 1, <10% improvement; and 2, ≥10% improvement. Urinary disturbance was coded as absent (0) or present (1).

†Scores were assigned using the magnetic resonance imaging-based DESH scoring system, and their sum yielded the total DESH score.

‡The score was 0 for normal findings, including a “pencil-thin lining” along the ventricular wall and small caps around the frontal horns; 1 for increased periventricular hyperintensity; and 2 for large, irregular, symmetric hyperintensities extending into the deep white matter and, in at least two locations, from the ventricles to the cortex.

Table 3.
Comparison of clinical and radiological characteristics by shunt response
Variable Nonresponders (n=8) Responders (n=28) p-value
Age (yr) 69.13±2.27 72.86±1.53 0.221†
Symptom duration (mo) 27.75±8.71 24.50±4.88 0.466†
Urinary disturbance 8 (100.0) 21 (75.0) 0.309‡
MMSE 18.38±2.81 22.07±0.75 0.349†
Tap test response score 0.044*‡
 0 3 (37.5) 4 (14.3)
 1 4 (50.0) 8 (28.6)
 2 1 (12.5) 16 (57.1)
DESH score 5.38±1.03 5.00 ± 0.41 0.695†
Evans index 0.37±0.02 0.37 ± 0.01 0.808†
Callosal angle (°) 95.64±10.96 99.76 ± 3.98 0.668†
Sylvian fissure widening 7 (87.5) 22 (78.6) >0.99
High-convexity sulcal narrowing 5 (62.5) 11 (39.3) 0.414‡
Focally enlarged sulci 5 (62.5) 14 (50.0) 0.857‡
Right temporal horn width (mm) 8.60±1.63 8.81±0.54 0.489†
Left temporal horn width (mm) 8.13±1.07 8.87±0.52 0.614†
Periventricular hyperintensity 6 (75.0) 12 (42.9) 0.250‡

Values are presented as mean±standard error or number (%). MMSE: Mini-Mental State Examination, DESH: disproportionately enlarged subarachnoid space hydrocephalus.

*Statistical significance was defined as a two-sided p-value <0.05.

†Mann-Whitney U-test.

‡Fisher’s exact test.

Table 4.
Multivariable logistic regression analysis of responder status
Variable Adjusted OR 95% CI p-value
DESH score 0.955 0.508-1.795 0.885
Periventricular hyperintensity 0.813 0.191-3.450 0.778
Right temporal horn width 0.943 0.608-1.462 0.792
Left temporal horn width 1.317 0.759-2.284 0.328
High-convexity sulcal narrowing 0.953 0.131-6.928 0.962
Positive tap test response 3.725 0.863-16.083 0.078

A tap test response was considered positive if the response score was 2, indicating improvement of at least 10%. DESH: disproportionately enlarged subarachnoid space hydrocephalus, OR: odds ratio, CI: confidence interval.

REFERENCES

1. Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with “normal” cerebrospinal-fluid pressure. a treatable syndrome. N Engl J Med 1965;273:117-26
crossref pmid
2. Mori E, Ishikawa M, Kato T, Kazui H, Miyake H, Miyajima M, et al. Guidelines for management of idiopathic normal pressure hydrocephalus: second edition. Neurol Med Chir (Tokyo) 2012;52:775-809
crossref pmid
3. Giordan E, Palandri G, Lanzino G, Murad MH, Elder BD. Outcomes and complications of different surgical treatments for idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis. J Neurosurg 2018;131:1024-36
crossref pmid
4. Toma AK, Papadopoulos MC, Stapleton S, Kitchen ND, Watkins LD. Systematic review of the outcome of shunt surgery in idiopathic normal-pressure hydrocephalus. Acta Neurochir (Wien) 2013;155:1977-80
crossref pmid pdf
5. Black PM. Idiopathic normal-pressure hydrocephalus. Results of shunting in 62 patients. J Neurosurg 1980;52:371-7
crossref pmid
6. Grahnke K, Jusue-Torres I, Szujewski C, Joyce C, Schneck M, Prabhu VC, et al. The quest for predicting sustained shunt response in normal-pressure hydrocephalus: an analysis of the callosal angle’s utility. World Neurosurg 2018;115:e717-22
crossref pmid
7. Shinoda N, Hirai O, Hori S, Mikami K, Bando T, Shimo D, et al. Utility of MRI-based disproportionately enlarged subarachnoid space hydrocephalus scoring for predicting prognosis after surgery for idiopathic normal pressure hydrocephalus: clinical research. J Neurosurg 2017;127:1436-42
crossref pmid
8. Kitagaki H, Mori E, Ishii K, Yamaji S, Hirono N, Imamura T. CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry. AJNR Am J Neuroradiol 1998;19:1277-84
pmid pmc pdf
9. Nakajima M, Yamada S, Miyajima M, Ishii K, Kuriyama N, Kazui H, et al. Guidelines for management of idiopathic normal pressure hydrocephalus (third edition): endorsed by the Japanese Society of Normal Pressure Hydrocephalus. Neurol Med Chir (Tokyo) 2021;61:63-97
crossref pmid pmc
10. Adachi M, Kawanami T, Ohshima F, Kato T. Upper midbrain profile sign and cingulate sulcus sign: MRI findings on sagittal images in idiopathic normal-pressure hydrocephalus, Alzheimer’s disease, and progressive supranuclear palsy. Radiat Med 2006;24:568-72
crossref pmid pdf
11. Hashimoto M, Ishikawa M, Mori E, Kuwana N; Study of INPH on neurological improvement (SINPHONI). Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res 2010;7:18
crossref pmid pmc
12. Ishii K, Kanda T, Harada A, Miyamoto N, Kawaguchi T, Shimada K, et al. Clinical impact of the callosal angle in the diagnosis of idiopathic normal pressure hydrocephalus. Eur Radiol 2008;18:2678-83
crossref pmid pdf
13. Garcia-Armengol R, Domenech S, Botella-Campos C, Goncalves FJ, Menéndez B, Teixidor P, et al. Comparison of elevated intracranial pressure pulse amplitude and disproportionately enlarged subarachnoid space (DESH) for prediction of surgical results in suspected idiopathic normal pressure hydrocephalus. Acta Neurochir (Wien) 2016;158:2207-13
crossref pmid pdf
14. Ishikawa M, Oowaki H, Takezawa M, Takenaka T, Yamada S, Yamamoto K, et al. Disproportionately enlarged subarachnoid space hydrocephalus in idiopathic normal-pressure hydrocephalus and its implication in pathogenesis. Acta Neurochir Suppl 2016;122:287-90
crossref pmid
15. Virhammar J, Laurell K, Cesarini KG, Larsson EM. Preoperative prognostic value of MRI findings in 108 patients with idiopathic normal pressure hydrocephalus. AJNR Am J Neuroradiol 2014;35:2311-8
crossref pmid pmc
16. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 2007;38:1091-6
crossref pmid
17. Meier U, Miethke C. Predictors of outcome in patients with normal-pressure hydrocephalus. J Clin Neurosci 2003;10:453-9
crossref pmid
18. Eide PK, Stanisic M. Cerebral microdialysis and intracranial pressure monitoring in patients with idiopathic normal-pressure hydrocephalus: association with clinical response to extended lumbar drainage and shunt surgery. J Neurosurg 2010;112:414-24
crossref pmid
19. Governale LS, Fein N, Logsdon J, Black PM. Techniques and complications of external lumbar drainage for normal pressure hydrocephalus. Neurosurgery 2008;63(4 Suppl 2):379-84
crossref pmid
20. Marmarou A, Young HF, Aygok GA, Sawauchi S, Tsuji O, Yamamoto T, et al. Diagnosis and management of idiopathic normal-pressure hydrocephalus: a prospective study in 151 patients. J Neurosurg 2005;102:987-97
crossref pmid
21. McGirt MJ, Woodworth G, Coon AL, Thomas G, Williams MA, Rigamonti D. Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus. Neurosurgery 2005;57:699-705
crossref pmid
22. Walchenbach R, Geiger E, Thomeer RT, Vanneste JA. The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2002;72:503-6
crossref pmid pmc
23. Woodworth GF, McGirt MJ, Williams MA, Rigamonti D. Cerebrospinal fluid drainage and dynamics in the diagnosis of normal pressure hydrocephalus. Neurosurgery 2009;64:919-26
crossref pmid pdf
24. Radovnický T, Adámek D, Derner M, Sameš M. Fractional anisotropy in patients with disproportionately enlarged subarachnoid space hydrocephalus. Acta Neurochir (Wien) 2016;158:1495-500
crossref pmid pdf
25. Momjian S, Owler BK, Czosnyka Z, Czosnyka M, Pena A, Pickard JD. Pattern of white matter regional cerebral blood flow and autoregulation in normal pressure hydrocephalus. Brain 2004;127:965-72
crossref pmid
26. Ziegelitz D, Arvidsson J, Hellström P, Tullberg M, Wikkelsø C, Starck G. Pre- and postoperative cerebral blood flow changes in patients with idiopathic normal pressure hydrocephalus measured by computed tomography (CT)-perfusion. J Cereb Blood Flow Metab 2016;36:1755-66
crossref pmid pdf
27. Akai K, Uchigasaki S, Tanaka U, Komatsu A. Normal pressure hydrocephalus. Neuropathological study. Acta Pathol Jpn 1987;37:97-110
crossref pmid
28. Park HY, Park CR, Suh CH, Kim MJ, Shim WH, Kim SJ. Prognostic utility of disproportionately enlarged subarachnoid space hydrocephalus in idiopathic normal pressure hydrocephalus treated with ventriculoperitoneal shunt surgery: a systematic review and meta-analysis. AJNR Am J Neuroradiol 2021;42:1429-36
crossref pmid pmc
29. Thavarajasingam SG, El-Khatib M, Vemulapalli K, Iradukunda HAS, K SV, Borchert R, et al. Radiological predictors of shunt response in the diagnosis and treatment of idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis. Acta Neurochir (Wien) 2023;165:369-419
crossref pmid pdf
30. Eide PK, Sorteberg W. Invasive tests for predicting shunt response in idiopathic normal pressure hydrocephalus: the risk aspect. Acta Neurochir (Wien) 2022;164:481-2
crossref pmid pdf
31. Greitz D. Radiological assessment of hydrocephalus: new theories and implications for therapy. Neurosurg Rev 2004;27:145-67
crossref pmid pdf
32. Greitz D. Paradigm shift in hydrocephalus research in legacy of Dandy’s pioneering work: rationale for third ventriculostomy in communicating hydrocephalus. Childs Nerv Syst 2007;23:487-9
crossref pmid pmc pdf
33. Raboel PH, Bartek J Jr, Andresen M, Bellander BM, Romner B. Intracranial pressure monitoring: invasive versus non-invasive methods: a review. Crit Care Res Pract 2012;2012:950393
crossref pmid pmc pdf
34. Boon AJ, Tans JT, Delwel EJ, Egeler-Peerdeman SM, Hanlo PW, Wurzer HA, et al. Dutch normal-pressure hydrocephalus study: the role of cerebrovascular disease. J Neurosurg 1999;90:221-6
crossref pmid
35. Casmiro M, D’Alessandro R, Cacciatore FM, Daidone R, Calbucci F, Lugaresi E. Risk factors for the syndrome of ventricular enlargement with gait apraxia (idiopathic normal pressure hydrocephalus): a case-control study. J Neurol Neurosurg Psychiatry 1989;52:847-52
crossref pmid pmc
36. Earnest MP, Fahn S, Karp JH, Rowland LP. Normal pressure hydrocephalus and hypertensive cerebrovascular disease. Arch Neurol 1974;31:262-6
crossref pmid
37. Graff-Radford NR, Godersky JC. Idiopathic normal pressure hydrocephalus and systemic hypertension. Neurology 1987;37:868-71
crossref pmid
38. Krauss JK, Regel JP, Vach W, Droste DW, Borremans JJ, Mergner T. Vascular risk factors and arteriosclerotic disease in idiopathic normal-pressure hydrocephalus of the elderly. Stroke 1996;27:24-9
crossref pmid
39. Tullberg M, Jensen C, Ekholm S, Wikkelsø C. Normal pressure hydrocephalus: vascular white matter changes on MR images must not exclude patients from shunt surgery. AJNR Am J Neuroradiol 2001;22:1665-73
pmid pmc pdf
40. Grazzini I, Venezia D, Cuneo GL. The role of diffusion tensor imaging in idiopathic normal pressure hydrocephalus: a literature review. Neuroradiol J 2021;34:55-69
crossref pmid pdf
41. Bech-Azeddine R, Høgh P, Juhler M, Gjerris F, Waldemar G. Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting. J Neurol Neurosurg Psychiatry 2007;78:157-61
crossref pmid
42. Keong NC, Lock C, Soon S, Hernowo AT, Czosnyka Z, Czosnyka M, et al. Diffusion tensor imaging profiles can distinguish diffusivity and neural properties of white matter injury in hydrocephalus vs. non-hydrocephalus using a strategy of a periodic table of DTI elements. Front Neurol 2022;13:868026
crossref pmid pmc
43. Hurley RA, Bradley WG Jr, Latifi HT, Taber KH. Normal pressure hydrocephalus: significance of MRI in a potentially treatable dementia. J Neuropsychiatry Clin Neurosci 1999;11:297-300
crossref pmid
44. Bradley WG Jr. magnetic resonance imaging of normal pressure hydrocephalus. Semin Ultrasound CT MR 2016;37:120-8
crossref pmid
45. Merali Z, Wang JZ, Badhiwala JH, Witiw CD, Wilson JR, Fehlings MG. A deep learning model for detection of cervical spinal cord compression in MRI scans. Sci Rep 2021;11:10473
crossref pmid pmc pdf
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 672 View
  • 11 Download
ORCID iDs

Eun Young Kim
https://orcid.org/0000-0002-4942-8425

Related articles


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
Department of Neurosurgery, Yonsei University College of Medicine
50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-2228-2150    Fax: +82-2-393-9979    E-mail: changws@yonsei.ac.kr / changws0716@yuhs.ac                

Copyright © 2026 The Korean Society of Stereotactic and Functional Neurosurgery.

Developed in M2PI

Close layer
prev next